All posts by imreal

Mother Earth Juice Bar Launches New Smoothie called “Fight Back”


Dr. Simone Lord

I’m on a mission to help people prosper and be in the best of health.”

Mother Earth Juice Bar has a new, delicious smoothie called, “Fight Back”, which packs a delicious, nutritious, powerful punch. The new smoothie is high in anti-oxidants and offers many health benefits. Mother Earth has been in business for three years and has been making great juices and smoothies with enticing names such as the “Immune Power”, the “Take Care of Me”, “Man Man Power”, “Liver Tonic”, “Toxin Free”. “Energy Booster”, “Energy Elixir”, “Digestive Delight” , the “Power Shot” and more since 2017.

Dr. Simone Lord, a naturopathic doctor and pastor, started Mother Earth Juice Bar & Health Foods “to help people to attain better health, especially in communities of color.,” said Dr. Lord. They specialize in freshly pressed natural juices, tonics, elixirs, loose herbs, teas, herbal remedies and hot meals to help clients boost their health..

Mother Earth Juice Bar is helping people worldwide to restore optimum health and wellness by arming them with juice and smoothie recipes as well as herbal remedies. Dr. Lord’s patent pending Olive Leaf Tea Formula and Amazing Oil have clients coming back for more each day.

Dr. Simone Lord is the author of five books and has been on a mission to help people live their best, healthiest lives since 2006. She is a practicing pastor and naturopath with a church and wellness center in Jamaica Queens, called Inspire NY. Dr. Lord is currently ‘seeing’ clients via Facetime and utilizing technology to read their irises for the purpose of Iridology. She then makes recommendations based on the consultation and markings that she sees in their eyes, tongue, nails and skin.

Please visit http://www.motherearthjuice.com for more information on maintaining the best of health.

Share article on social media or email:

Asthma Not Associated With Increased Risk of Hospitalization Among COVID-19 Patients


AAAAI Logo

“More studies must be done to look at the underlying immune modulation caused by asthma or asthma treatment to see what impact it may have on COVID-19 outcomes.” – Anju T. Peters, MD, MSCI, FAAAAI

According to research from The Journal of Allergy and Clinical Immunology (JACI), patients with asthma were not more likely to be hospitalized due to COVID-19 than those without asthma. This finding comes despite asthmatics being more prevalent in the study’s cohort than would be expected given the estimates of asthma prevalence nationwide.

This study set out to examine the prevalence of asthma and comorbidities in asthmatics with COVID-19. In addition, researchers determined the risk of hospitalization due to COVID-19 in asthmatics and looked at inhaled corticosteroid use and risk of hospitalization due to COVID-19.

The retrospective study was conducted across 10 hospitals affiliated with Northwestern

Medicine via automated chart review using Northwestern Medicine’s Enterprise Data Warehouse, an electronic repository of health records. In total, 1,526 patients with COVID-19 were identified and used in the study. Of those, 220 (14.4%) had asthma, which is significantly higher than the national asthma prevalence rate of eight to nine percent. These numbers were in line with published U.S. data from the Centers for Disease Control and Prevention’s Morbidity and Mortality Weekly Report during the study period.

Two models were used to examine if asthma was a risk for hospitalization due to COVID-19. The first model adjusted for demographic data including age, gender, and ethnicity, while the second model also adjusted for multiple risk factors, including smoking and obesity. In both models, there was no significant difference in the risk of hospitalization between asthmatics and non-asthmatics.

The prevalence of many comorbidities including obesity, hypertension, sleep apnea, COPD, and gastroesophageal reflux disease was higher in patients with asthma and COVID-19 than in non-asthmatics with COVID-19. However, these comorbidities did not translate to a higher rate of hospitalization in asthmatics compared to non-asthmatics with COVID-19. Patients with asthma also had a higher prevalence of allergic rhinitis, rhinosinusitis, and immunodeficiencies. Interestingly, rhinosinusitis was associated with a lower risk of hospitalization.

Dramatic racial disparities have been reported during the COVID-19 pandemic and this was true in this study. Non-Hispanic African Americans and Hispanics or Latinos comprised a significant proportion of the asthma cohort with COVID-19 and had higher likelihood of COVID-19 related hospitalizations in general.

Chart review was completed to document which asthmatic patients with COVID-19 had a prescription of an inhaled corticosteroid (ICS), combination inhaled corticosteroid plus long-acting beta-agonist (ICS/LABA), and/or systemic corticosteroids. Only one patient was on a biologic. Just under half (48.2%) of the patients were prescribed the aforementioned medications, and in general the risk of hospitalization for these patients was not significantly greater than for those not on them.

There was also no observable difference in mortality rates between patients with COVID-19 who had asthma and those who did not. Laboratory assessment actually saw lower levels of biomarkers used to identify COVID-19 severity in patients with asthma, though additional studies must be performed to understand why this is and if asthmatics may have any protection against the virus.

“We would usually expect for asthmatic patients to have worse outcomes, as viral illness often can set off asthma exacerbations,” said Anju T. Peters, MD, MSCI, FAAAAI, corresponding author of the study. “More studies must be done to look at the underlying immune modulation caused by asthma or asthma treatment to see what impact it may have on COVID-19 outcomes.”

Another limitation of the study, according to Dr. Peters, was that they were not able to assess the contribution of asthma severity or asthma endotypes to COVID-19 disease severity and cautioned that healthcare workers need to be vigilant of older patients, those with certain comorbidities, African Americans, and Hispanics as they are at increased risk of hospitalization in general due to COVID-19.

You can learn more about asthma and COVID-19 on the American Academy of Allergy, Asthma & Immunology website, aaaai.org.

The American Academy of Allergy, Asthma & Immunology (AAAAI) represents allergists, asthma specialists, clinical immunologists, allied health professionals and others with a special interest in the research and treatment of allergic and immunologic diseases. Established in 1943, the AAAAI has more than 7,100 members in the United States, Canada and 72 other countries. The AAAAI’s Find an Allergist/Immunologist service is a trusted resource to help you find a specialist close to home.

Share article on social media or email:

Prestige Maintenance USA Adds Another CIMS Green Building to Their Client List


Prestige Maintenance USA announced that another CIMS-Green Building was added to their client list. The additional CIMS Green Building client, a manufacturing company, joins Offices@Mall of America in Minneapolis and other CIMS Green Building facilities that are clients of Prestige. Compliance with the ISSA Cleaning Industry Management Standard (CIMS) and CIMS-Green Building (GB) certification standard shows that a cleaning organization has the systems in place to deliver consistent, professional services designed to meet customer needs and expectations and is prepared to deliver a comprehensive green cleaning program based on LEED EB: O&M green cleaning criteria. CIMS and CIMS-GB certification are required in many cleaning service bid specifications as customers look for an effective way to identify high-quality providers committed to customer satisfaction. Prestige Maintenance USA recertifies every two years showing consistent compliance to the standard.

Manufacturing facilities are increasingly seeking LEED green building certification, according to a US Green Building Council report. LEED in Motion: Industrial Facilities report highlights the manufacturing sector’s efforts to design and implement LEED and prioritize environmental stewardship. Currently, there are more than 1,755 LEED-certified industrial facilities worldwide, totaling more than 496 million square feet, and an additional 2,710 projects registered that total nearly 737 million square feet. Why this boost in more sustainable manufacturing facilities? Because green buildings save money for owners and operators.

“The clients we work with have high standards, and this certification helps us communicate to them that we are able to meet and exceed their standards of excellence. Our processes and procedures ensure that every team member across the country can deliver for our clients, including LEED EB green cleaning criteria,” says Rachel Sanchez, CEO of Prestige Maintenance USA. “Mall of America® is committed to sustainable energy initiatives through best operational practices, cutting edge technology and long-term investments,” she added.

“Our use of technology and analytics gives us an edge in maintaining our high standards. Our clients get access to monthly inspections online in addition to the ability to communicate changes or needs to us. We know that our reputation depends on reliability and excellence, and we take it very seriously,” according to Jason Dinverno, Managing Partner and CXO at Prestige Maintenance USA.

About Prestige Maintenance USA

Prestige Maintenance USA is a national facility maintenance company based in Plano, Texas, providing cleaning, preventative maintenance and building maintenance management. Since 1976, they have been known for consistently delivering the highest quality services at a highly competitive price. Local managers and 2000+ long-tenured, W-2 employees, deliver custom, scalable, and flexible services across multiple industries: commercial, distribution, manufacturing and retail. Their technology and analytics provide insights into how they are performing and how to improve. It’s a competitive advantage for the company and a time-saving tool for clients with online monthly inspections and ways to incorporate work order changes with the touch of a button.

Share article on social media or email:

Mount Sinai Health System Appoints Beth Oliver, DNP, RN, as Senior Vice President and Chief Nursing Executive


Mount Sinai Health System has appointed Beth Oliver, DNP, RN, to the role of Senior Vice President and Chief Nursing Executive.

In this newly created role, Dr. Oliver will be responsible for the practice of nursing across the health system and will collaborate with the senior executive team as well as the chief nursing officers throughout Mount Sinai.

“As Chief Nursing Executive, her top three priorities will be ensuring the safety and quality of care for our patients, transforming the care we provide, and decreasing the overall costs of that care. These priorities, when well implemented, will improve patient experience,” said Kenneth L. Davis, MD, President and Chief Executive Officer of the Mount Sinai Health System. “In addition, Dr. Oliver will continue to develop and maintain Mount Sinai’s national reputation for excellence in nursing services. In collaboration with executive leadership and the Chief Nursing Officers, she will participate in the organization’s strategic plan—setting annual and long-term performance goals—and will leverage the Health System’s nursing excellence to advance the achievement of strategic goals, optimize clinical outcomes, enhance employee engagement, and promote a best-in-class patient experience.”

A nationally recognized cardiovascular leader, Dr. Oliver has fostered and supported evidence-based, patient-centered care throughout her career. For more than 28 years, Dr. Oliver has been a transformational cardiac nurse leader at Mount Sinai, most recently serving as Senior Vice President of Cardiac Services for the Health System, in which she leads cardiovascular service line strategy and operations for the Health System while also being responsible for ensuring the delivery of quality care to Mount Sinai Heart patients.

In addition to her Mount Sinai leadership roles, Dr. Oliver has led numerous cardiovascular health-related community outreach programs in partnership with the American Heart Association. In July 2018, Dr. Oliver was appointed President of the American Heart Association’s Board of Directors in New York City, becoming the first nurse to hold the position of Board President.

As a clinician, an executive, and a nurse, Dr. Oliver is committed to advancing population health and the current and future role of nurses in achieving this goal.

Dr. Oliver received her MS from Columbia University and her DNP from Case Western Reserve University.

About the Mount Sinai Health System

The Mount Sinai Health System is New York City’s largest academic medical system, encompassing eight hospitals, a leading medical school, and a vast network of ambulatory practices throughout the greater New York region. Mount Sinai is a national and international source of unrivaled education, translational research and discovery, and collaborative clinical leadership ensuring that we deliver the highest quality care—from prevention to treatment of the most serious and complex human diseases. The Health System includes more than 7,200 physicians and features a robust and continually expanding network of multispecialty services, including more than 400 ambulatory practice locations throughout the five boroughs of New York City, Westchester, and Long Island. The Mount Sinai Hospital is ranked No. 14 on U.S. News & World Report’s “Honor Roll” of the Top 20 Best Hospitals in the country and the Icahn School of Medicine as one of the Top 20 Best Medical Schools in country. Mount Sinai Health System hospitals are consistently ranked regionally by specialty and our physicians in the top 1% of all physicians nationally by U.S. News & World Report.

For more information, visit https://www.mountsinai.org or find Mount Sinai on Facebook, Twitter and YouTube.

Share article on social media or email:

OMERS Selects Vision Critical to Uncover Insights that Strengthen the Pension Experience


Omers + Vision Critical

Partnering with Vision Critical allows us to deeply engage them in new channels, more often and in more meaningful ways. Ultimately, OMERS and its members are co-creating a better pension experience together with the help of Vision Critical, and we look forward to continuing to innovate with them.

Vision Critical, a continuous customer insights solution provider, today announced that OMERS, one of Canada’s largest defined benefit pension plans, has selected its Sparq digital insights platform and Touchpoint cloud-based app to uncover member insights that unlock real-time feedback to build a better pension experience, deliver better services, and achieve better business outcomes.

“Our members are the reason we exist, and we want to deliver the best pension experience possible,” said Jordan Ostapchuk, Vice President of Innovation, OMERS. “Partnering with Vision Critical allows us to deeply engage them in new channels, more often and in more meaningful ways. Ultimately, OMERS and its members are co-creating a better pension experience together with the help of Vision Critical, and we look forward to continuing to innovate with them.”

Touchpoint is Vision Critical’s new cloud-based application that enables brands to create quick and engaging interactions with broader customer bases while also extending the already deep functionality within the Sparq platform to collect actionable customer insights. The app allows companies to connect with their current and prospective customers where they spend time already, whether web, eCommerce, social media, or messaging platforms, providing powerful engagement with individuals to collect broad feedback and then recruit them into an insight community through Sparq.

Vision Critical’s flagship digital insights platform, Sparq, helps companies get the richest insights into their customers’ behaviors and attitudes on a regular – and immediate – basis. Sparq helps proactively drive informed actions and better business outcomes based on customer insights, as well as build customer trust and lifetime value by showing customers how their feedback is being applied.

The insights platform also gives brands the power to connect live/virtual experiences with digital customer feedback to inform their critical business decisions. Integrating with technologies such as Zoom, brands are able to form an even deeper personal connection with their customers.

OMERS has been a true partner in innovation,” said Ross Wainwright, CEO of Vision Critical. “Our collaboration exemplifies the respect they have for their members and their focus to build exceptional pension experiences. This partnership will only accelerate that journey by uncovering invaluable insights that create long-standing outcomes for their entire member and retiree base.”

OMERS will also utilize Jumpstart, Vision Critical’s new streamlined onboarding program which provides a fully remote launch experience for customers. The program focuses on empowering new users to launch their services and insights communities in just 5 days.

Vision Critical is on an aggressive growth path with a relentless focus on the customer experience. Starting 2020 with a new executive leadership team on board, the company continues to make bold moves as it transforms into a value-based CXM leader. You can expect to see more from Vision Critical as it helps create a world where customers are respected as experts and treated as individuals.

About Vision Critical

Vision Critical is a continuous customer insights solution provider that enables organizations to drive better business outcomes while ensuring world-class customer journeys. By combining deep insight with broad feedback, Vision Critical empowers some of the most powerful brands in the world to improve customer experience. Over 750 leading brands including BuzzFeed, LinkedIn, and GoDaddy are building better products and fostering customer loyalty with Vision Critical. To learn more about Vision Critical, follow us on LinkedIn, Facebook, and Twitter, or visit us at http://www.visioncritical.com

Share article on social media or email:



Jeff Hawkins, Veteran Retail Real Estate Expert Joins Blue Butterfly as Managing Director, Global Real Estate


News Image

We recognize that right now the marketplace needs an efficient solution to deliver new tenants and to help retailers recover and prosper. Jeff joining our team cements Blue Butterfly’s position as the market’s go to resource.

Blue Butterfly, a strategic consultancy for the retail real estate industry, announces the appointment of Jeff Hawkins as the Managing Director, Global Real Estate. Hawkins will be responsible for global leasing at Blue Butterfly.

“Jeff’s deep experience in both specialty leasing and retail enables him to develop creative deal making opportunities for our clients during this unprecedented time. We recognize that right now the marketplace needs an efficient solution to deliver new tenants and to help retailers recover and prosper. Jeff joining our team cements Blue Butterfly’s position as the market’s go to resource,” said Michael Brielmann, Partner at Blue Butterfly.

Commenting on his new role, Hawkins said, “I am thrilled to be part of the Blue Butterfly senior management team. I am in a unique position to help both landlords and retailers develop strategies to capitalize on today’s opportunities. Blue Butterfly has built a strong and durable business model that has produced outstanding results for their clients. I look forward to building upon the team’s success.”

Hawkins has more than forty years of experience in the retail real estate industry. He joins Blue Butterfly from Simon Property Group, where he most recently served as SVP, Retailer Development. Simon is a global leader in retail real estate, and an S&P 100 company. Simon’s 209 properties are located around the globe and fall under three brands including Simon Malls, Simon Premium Outlets®, and The Mills®. During his twenty-two year tenure at Simon, Hawkins was responsible for negotiating thousands of deals, and leasing millions of square feet with iconic brands, start-up entrepreneurs, service providers, and pure play e-Tailers seeking first time brick-and-mortar locations.

“Blue Butterfly’s mission is twofold: propelling our clients’ growth, and proactively addressing and solving industry challenges. With Jeff’s extensive connections in the industry and his vast experience, we will have a much wider network that will lead to innovative new opportunities for our clients and the industry. It is very exciting to see our team grow,” said Patricia Norins, Partner at Blue Butterfly.

Share article on social media or email:

Announcing RevSpring Arrived™ Parking Lot Waiting Room Application


“RevSpring Arrived™ reduces the potential exposure to others with COVID-19 or other infectious diseases and gives providers more control over the flow of patients in their facilities at one time,” said RevSpring vice president of patient engagement Howard Bright.

RevSpring, the leading provider of healthcare financial engagement and payment solutions, today announced a new pre-appointment, virtual waiting room application that enables contactless patient check-in, visit prep, and payment collection from their cell phone in their car. RevSpring Arrived™ connects patients and front office staff digitally, with easy-to-use check-in communications and co-payment processing to safely and efficiently welcome and prepare patients for their appointments.

“RevSpring is pleased to provide another swift innovation in response to the challenges facing healthcare providers as they accept patients and adhere to social distancing requirements,” said RevSpring CEO Scott MacKenzie. “Arrived helps solve the short-term challenges of minimizing waiting room contact in the wake of the highly infectious coronavirus. Clients will also appreciate the long-term impact of collecting co-payments without burdening already busy registrars.”

From parking lots to living rooms to their kids’ lacrosse games, the bottom line will be check-in-anywhere convenient for providers and their patients, along with safer in-person interactions for everyone.

Arrived (found at Arrived.care) is available as a stand-alone application for any provider in need of secure check-in communication—including online registration and customizable text messages. Optionally, Arrived integrates with RevSpring’s Talksoft® appointment reminder platform for a consistent and smooth patient communication process. Patients also will be digitally empowered to make payments from anywhere through the application prior to healthcare visits.

Front office staff using Arrived can monitor virtual patient check-ins using a specially designed dashboard. Patients benefit from using Arrived in a variety of settings including waiting for their appointments in a parking lot or having a contactless experience in a healthcare waiting room. Arrived can also be used to encourage patients to answer basic questions or review safety protocols prior to appointments.

Arrived is a flexible digital solution that provides peace of mind as it protects patients and providers. Using proven technologies for pre-service engagement and payment, it’s a natural extension to RevSpring’s comprehensive patient financial engagement platform and a crucial solution as more patients return for facility visits.

“Arrived reduces the potential exposure to others with COVID-19 or other infectious diseases and gives providers more control over the flow of patients in their facilities at one time,” said RevSpring vice president of patient engagement Howard Bright. “We expect that its functionality will continue evolving in response to client feedback, and as providers realize the financial benefits Arrived helps facilitate.”

About RevSpring

RevSpring leads the market in financial communications and payment solutions that inspire patients to participate in and pay for their healthcare. The company has built the industry’s most comprehensive and impactful suite of patient engagement, OmniChannel communications and payment solutions backed by behavior analysis, propensity-to-pay scoring, contextual messaging, and user experience best practices. Using proprietary data analytics to tailor the engagement from pre-service to post-service, we improve the financial experience and outcomes for providers and their patients. To learn more, visit revspringinc.com/healthcare.

Share article on social media or email:

Vertebrae Launches Retail’s First Web-Based Virtual Try-On with Accurate Size & Scale


Using Vertebrae, we can create, manage, and deploy high-quality 3D and AR experiences that are more realistic than ever, enabling shoppers to virtually experience wearing our hats with a high degree of accuracy. – Carson Finkle, CEO of Tenth Street Hats.

Vertebrae, the technology leader in 3D & augmented reality (AR) solutions for retail, today announced the debut of a powerful new tool for retailers that enables shoppers to virtually try on items with the highest degree of accuracy – all within the mobile browsing experience. For the first time, digital items such as sunglasses, hats, jewelry, and apparel can be superimposed onto a shopper’s head or body at the precise size and scale that the products are in real life, so that each individual can see precisely how it looks on them – all without going into a physical store or downloading an app. These breakthrough web-based try-on experiences ensure that Vertebrae and its clients are at the forefront of retail’s transformation during the COVID-19 pandemic.

“Now more than ever, it’s crucial for retailers to help boost consumers’ confidence, and that means setting them at ease about purchasing and giving them accurate information about size and fit — even without physical changing rooms,” said Vince Cacace, CEO of Vertebrae. “This is the perfect solution for shoppers who want to see and experience a product, but don’t necessarily feel comfortable going into a store to try them on. And because our solution is Web-based, retailers can deploy these virtual try-on experiences in any digital channel, all through a single platform.”

Vertebrae’s patented 3D and AR platform makes creating, managing, and deploying frictionless accurate size and scale experiences possible. For accurate size and scale experiences, Vertebrae uses data from smartphones with front-facing depth cameras to dynamically map the proportions of individual facial features and overlay accurate product renderings to scale and in the right position, even as shoppers move around to view the results from different angles. The experience debuted on direct-to-consumer retailer Tenth Street Hats, which offers shoppers the ability to virtually try on top-selling hats directly from the eCommerce experience on mobile. Shoppers on desktop computers or older mobile phones without a front-facing depth camera still receive a highly engaging AR experience that provides a confidence-boosting style check, but not precisely to size and scale.

“Using Vertebrae, we can create, manage, and deploy high-quality 3D and AR experiences that are more realistic than ever, enabling shoppers to virtually experience wearing our hats with a high degree of accuracy,” said Carson Finkle, CEO of Tenth Street Hats. “The assets are available for deployment across the Web, not just in custom apps, giving our customers broad access to the tools that motivate purchasing without needing a dedicated team of developers. ”

The 3D and AR experiences are accessible via Tenth Street’s home page and via product pages, so viewers never leave the shopping environment during the virtual try-on session, which instantaneously sizes and displays items in proportion to shoppers’ heads without needing reference objects such as rulers or credit cards in the camera frame.

About Vertebrae

Vertebrae provides 3D & augmented reality (AR) commerce solutions for the world’s largest retailers. Vertebrae’s technology enables web-based 3D & AR product visualization and try-on experiences that drive measurable results. The end-to-end platform makes the process of 3D asset creation, management, deployment, and reporting easy. Vertebrae’s clients include Adidas, Toyota, Crate & Barrel, Herschel Supply Co., Facebook, Coach, Microsoft, and many more. Vertebrae is headquartered in Santa Monica with offices in Austin. For more information, visit https://www.vertebrae.com.

Share article on social media or email:

COVID-19 Clinical Trial of Immune Therapy Open at Mount Sinai, Made Possible by Philanthropic Donation


Mount Sinai Health System is beginning the first clinical trial in the New York metropolitan region of an immune-boosting therapy in COVID-19 patients.

The Phase 2 randomized trial is expected to recruit 66 patients to study peginterferon lambda in hospitalized patients receiving supplemental oxygen. Peginterferon lambda is injected under the skin as a single, one-time dose, and scientists believe it can help the immune system control the virus infection, decreasing the duration and severity of COVID-19.

“There is significant evidence from laboratory studies done here at Mount Sinai and abroad that patients’ own immune systems are making inadequate amounts of interferon lambda—an alert signal the lungs normally send out to the immune system that a virus is present—when patients are infected with the coronavirus causing COVID-19,” said trial principal investigator Thomas Marron, MD, PhD, Assistant Director of Early Phase and Immunotherapy Clinical Trials at The Tisch Cancer Institute at Mount Sinai. “As naturally occurring interferon lambda is the first line of defense against COVID-19, we have designed a clinical trial that will quickly determine whether treatment with peginterferon lambda will decrease the severity of COVID-19.”

Scientists at Mount Sinai knew about peginterferon lambda from Phase 3 trials for viral hepatitis and felt its antiviral properties would be beneficial to COVID-19 patients based on studies in mouse models. Scott Friedman, MD, Dean for Therapeutic Discovery at the Icahn School of Medicine at Mount Sinai, sought out the maker of the therapy, Eiger Biopharmaceuticals.

Together with Eiger, Dr. Friedman also sought funding from the COVID-19 Early Treatment Fund started by Silicon Valley entrepreneur and philanthropist Steve Kirsch, who in turn found matching funds from donors that include Corrigan Walla Foundation and David Baszucki, the founder and CEO of Roblox Corporation, and his wife, author Jan Ellison Baszucki. The total monetary donation was $500,000, and Eiger Biopharmaceuticals donated the drug for the trial.

“This collaboration between scientists and private industry is what can foster needed drug development for patients during this unprecedented pandemic,” Dr. Friedman said. “We’re hopeful about the prospects for peginterferon lambda based on its activity against SARS-CoV-2, the virus that leads to COVID-19, in cultured cells and animal models and because of its safety in thousands of patients who have received the drug for other conditions. This clinical trial will be important to determine if the drug has activity against COVID-19 in patients.”

Other sites are testing peginterferon lambda’s effectiveness prophylactically and in outpatients with mild COVID-19 cases. Mount Sinai’s Human Immune Monitoring Center, led by Miriam Merad, MD, PhD, Director of the Precision Immunology Institute at the Icahn School of Medicine at Mount Sinai, will perform extensive analysis of patients’ blood to characterize the response to the peginterferon lambda, and help determine if it is effective in activating the immune system to attack the coronavirus.

About the Mount Sinai Health System

The Mount Sinai Health System is New York City’s largest academic medical system, encompassing eight hospitals, a leading medical school, and a vast network of ambulatory practices throughout the greater New York region. Mount Sinai is a national and international source of unrivaled education, translational research and discovery, and collaborative clinical leadership ensuring that we deliver the highest quality care—from prevention to treatment of the most serious and complex human diseases. The Health System includes more than 7,200 physicians and features a robust and continually expanding network of multispecialty services, including more than 400 ambulatory practice locations throughout the five boroughs of New York City, Westchester, and Long Island. The Mount Sinai Hospital is ranked No. 14 on U.S. News & World Report’s “Honor Roll” of the Top 20 Best Hospitals in the country and the Icahn School of Medicine as one of the Top 20 Best Medical Schools in country. Mount Sinai Health System hospitals are consistently ranked regionally by specialty and our physicians in the top 1% of all physicians nationally by U.S. News & World Report.

For more information, visit https://www.mountsinai.org or find Mount Sinai on Facebook, Twitter and YouTube.

Share article on social media or email:

Inventive Sleep™ to Launch New Sleep Wellness Blog


Promoting feel-good experiences has never been more important.

Sleep Products Innovator Tracy Laskowski Miller will soon be sharing her sleep products and tips through her newly launched blog and website. Tracy has combined her background in material research and design to help consumers find the most functional sleep products that work for them. The blog will highlight the best features about her products, proven and emerging sleep technologies, as well as the secrets to a good night’s sleep, according to her and other leading experts.

“I am always inspired by all the stories people share with me on how a great night’s sleep plays a role in their lives,” says Tracy Laskowski Miller, Sleep Products Innovator and Founder of Inventive Sleep. “A favorite pillow, or blanket has uplifted people’s spirits for decades, helping them deal with the stresses of life and, I believe, inspiring them to share these feelings with their friends and family. Promoting feel-good experiences has never been more important, and this is at the heart of the Sleep Secrets and Inspirations content.”

The blog will be posting new articles and interviews several times a week, and new post announcements can be found on Inventive Sleep’s social media pages. The first few posts will feature cooling bedding products for the summer, an innovative new performance sheet from Pottery Barn Teen, and sleep recovery advice from a physical performance coach who has experience working with elite athletes including the Golden State Warriors and Chicago Bulls.

Tracy believes the sleep experience should be fun. She wants her audience to look forward to going to bed at night, and anticipate waking up in the morning feeling refreshed. Some bedding products are designed for functionality rather than fashion, and have the consumers’ well-being in mind at all times. The goal of Sleep Secrets and Inspirations is to help her audience find products they love in order to sleep better and feel better so that they can take on the world.

“Many people understand the benefits of getting a good night’s sleep,” says Tracy. “But there’s always questions on which products to buy, why, and how to use them. This makes people feel stressed, overwhelmed, and uncertain if they have purchased a product they will enjoy. We are demystifying the sleep experience with an informative and fun-filled conversation on how sleep helps people with everyday living. We will cover everything from health and wellness to beauty and construction, along with interviews with thought leaders to add some perspective.”

The blog is set to be launched Wednesday, June 10, 2020 and will be located at http://www.inventivesleep.com/blog.

To find out more information, visit http://www.inventivesleep.com or follow Inventive Sleep on Instagram at http://www.instagram.com/inventivesleep.

Share article on social media or email: